Immune cell expression analysis indicated that CDK6 expression level and risk positively correlated with M2 macrophages, which promote tumor development, progression (Zhao et al. 2020), and poor outcome (e.g., in colon cancer (Cheng et al. 2018)). Here, CDK6 is linked to neoplasm.